Vivan Hellström

High Posttransplant Cancer Incidence in Renal Transplanted Patients With Pretransplant Cancer

G. Enblad, G. Tufveson, T. Lorant, 2017, Transplantation.

Malignancies in transplanted patients: Multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation – experiences from a prospective, clinical, observational study

L. Holmberg, G. Opelz, G. Enblad, 2016, Acta oncologica.

The clinical perspective on malignancies in renal transplanted patients

Vivan Hellström, 2016 .

Intratumoral immunostimulatory AdCD40L gene therapy in patients with advanced solid tumors

A. Sundin, G. Ullenhag, G. Tufveson, 2020, Cancer Gene Therapy.

Regional Differences in Breast Cancer Survival Despite Common Guidelines

L. Holmberg, P. Dickman, M. Zack, 2005, Cancer Epidemiology Biomarkers & Prevention.

Risk Factors for De Novo Squamous Cell Carcinoma Development in Renal Transplant Recipients with a Previous Squamous Cell Carcinoma.

G. Enblad, G. Tufveson, T. Lorant, 2017, Acta dermato-venereologica.

Relative and absolute cancer risks among Nordic kidney transplant recipients—a population‐based study

D. O. Dahle, G. Mjøen, E. Pukkala, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

The Uppsala Experience of Switching from Cni:s to Belatacept after Kidney Transplantation

G. Tufveson, A. Sedigh, T. Lorant, 2013 .